| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elizabeth Simmons, Anna E Austi. Association of prenatal substance use with prenatal and postpartum care: Evidence from the pregnancy risk assessment monitoring system, 2016-2019. Preventive medicine. 2022-04-24. PMID:35461958. |
women who reported prenatal use of any opioids (risk difference(rd) = 0.16; 95% confidence interval (ci): 0.04, 0.28), prescription opioids (rd = 0.16; 95% ci = 0.04, 0.28), marijuana (rd = 0.25; 95% ci = 0.10, 0.41) and illicit drugs (rd = 0.52; 95% ci = 0.09, 0.95) initiated prenatal care later than those who did not report use of each substance. |
2022-04-24 |
2023-08-13 |
Not clear |
| Gillian L Schauer, Douglas R Roehler, Brooke E Hoot. Self-Reported Medical and Nonmedical Cannabis Use: Results from the 2018 Behavioral Risk Factor Surveillance System in 14 States. Journal of community health. 2022-04-23. PMID:35460471. |
overall, 28.6% (95% ci: 26.7, 30.4) of adults who use cannabis reported using cannabis medically, 34.2% (95% ci: 32.3, 36.2) nonmedically, and 37.2% (95% ci: 35.2, 39.2) both medically and nonmedically. |
2022-04-23 |
2023-08-13 |
Not clear |
| Manpreet Gill, Afrina Zaman, Jisha Kallikkadan, Oluwatoyin Oladeji, Samuel Adeyemo, Stanley Nkemjika, Terence Tumenta, Stephanie Madubuike, Gurraj Singh, Olalekan Olaolu, Tolu Olupon. Sociodemographic Attributes and Prevalence of Arrest With Possession of Substances in Incarcerated Population in the United States. Cureus. vol 14. issue 2. 2022-03-24. PMID:35321067. |
possession of cannabis at the time of arrest was highest in the age group 18-24 years compared to other age groups (odds ratio: 1.362; 95% ci: 1.159 - 1.602). |
2022-03-24 |
2023-08-13 |
Not clear |
| Christopher D Pfledderer, Yang Bai, Timothy A Brusseau, Ryan D Burns, Jessica L King Jense. Changes in college students' health behaviors and substance use after a brief wellness intervention during COVID-19. Preventive medicine reports. vol 26. 2022-03-04. PMID:35242504. |
statistically significant decreases in cannabis use (coef. = -2.3,95%ci:-4.1, -0.5) and alcohol consumption (coef. = -2.5,95%ci: -3.7,-1.3) were observed. |
2022-03-04 |
2023-08-13 |
human |
| Marjan Javanbakht, Allison Rosen, Amy Ragsdale, E India Richter, Steven Shoptaw, Pamina M Gorbac. Interruptions in Mental Health Care, Cannabis Use, Depression, and Anxiety during the COVID-19 Pandemic: Findings from a Cohort of HIV-Positive and HIV-Negative MSM in Los Angeles, California. Journal of urban health : bulletin of the New York Academy of Medicine. 2022-03-02. PMID:35235134. |
cannabis use for managing pandemic-related anxiety/depression was higher among those reporting changes in sexual activity (53% vs. 36%; p-value = 0.01) and was independently associated with having more than one sex partner in the prior 2 weeks (adjusted or = 1.5; 95% ci 1.0-2.4). |
2022-03-02 |
2023-08-13 |
human |
| Sung-Youn Chun, Ji W Yoo, Hyeki Park, Jinwook Hwang, Pearl C Kim, Seong Park, Jay J She. Trends and age-related characteristics of substance use in the hospitalized homeless population. Medicine. vol 101. issue 8. 2022-02-25. PMID:35212298. |
the subgroup analysis by age group was also conducted.homeless patients were associated with more use of opioid (rr [ci]), 1.23 [1.20-1.26], cocaine 2.55 [2.50-2.60], marijuana 1.43 [1.40-1.46], and heroin 1.57 [1.29-1.91] compared to other hospitalized patients. |
2022-02-25 |
2023-08-13 |
Not clear |
| George Sam Wang, Christine Buttorff, Asa Wilks, Daniel Schwam, Torri D Metz, Gregory Tung, Rosalie Liccardo Pacul. Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado. Preventive medicine. 2022-02-12. PMID:35150750. |
when comparing counties with different densities of baseline medical cannabis market, low and high exposure counties had fewer hospitalizations than those counties with no exposure (low: irr 0.97, ci: 0.96-0.99; high: 0.98, ci: 0.96-0.99). |
2022-02-12 |
2023-08-13 |
Not clear |
| Silvano Gallus, Chiara Stival, Giulia Carreras, Giuseppe Gorini, Andrea Amerio, Martin McKee, Anna Odone, Piet A van den Brandt, Lorenzo Spizzichino, Roberta Pacifici, Alessandra Lug. Use of electronic cigarettes and heated tobacco products during the Covid-19 pandemic. Scientific reports. vol 12. issue 1. 2022-01-14. PMID:35027590. |
new users were more frequently younger (p for trend 0.001), men (odds ratio, or 1.56; 95% confidence interval, ci: 1.03-2.34), cannabis users (or 2.35; 95% ci: 1.33-4.13), gamblers (or 3.34; 95% ci: 2.18-5.11) and individuals with anxiety symptoms (or 1.58; 95% ci: 1.00-2.52). |
2022-01-14 |
2023-08-13 |
human |
| Travis M Skipina, Nikhil Patel, Bharathi Upadhya, Elsayed Z Solima. Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score. The American journal of cardiology. 2021-12-21. PMID:34930616. |
ever cannabis use was associated with 60% increased odds of high-risk ascvd score (odds ratio [or] 95% confidence interval [ci] 1.60 [1.04 to 2.45], p = 0.03). |
2021-12-21 |
2023-08-13 |
human |
| Marie-Claude Couture, Jee Eun Kang, David Hemenway, Erin Grinshtey. Associations between having been threatened or injured with a weapon and substance use and mental health among high school students in the United States. International journal of injury control and safety promotion. 2021-12-20. PMID:34923925. |
after adjusting for covariates, having been threatened/injured with a weapon was associated with binge drinking (aor = 2.5; 95% ci: 1.9-3.4), marijuana (aor = 2.1; 95% ci: 1.6-2.7), tobacco use (aor = 2.6; 95% ci: 2.0-3.5), and misuse of prescription medication (aor = 2.2; 95% ci: 1.6-3.0) compared with students who have not been threatened/injured. |
2021-12-20 |
2023-08-13 |
Not clear |
| Lindsey Wang, QuanQiu Wang, Pamela B Davis, Nora D Volkow, Rong X. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World psychiatry : official journal of the World Psychiatric Association (WPA). 2021-12-12. PMID:34612005. |
breakthrough infection risk remained significantly higher after controlling for demographics (age, gender, ethnicity) and vaccine types for all sud subtypes, except for tobacco use disorder, and was highest for cocaine and cannabis use disorders (hazard ratio, hr=2.06, 95% ci: 1.30-3.25 for cocaine; hr=1.92, 95% ci: 1.39-2.66 for cannabis). |
2021-12-12 |
2023-08-13 |
Not clear |
| Lindsey Wang, QuanQiu Wang, Pamela B Davis, Nora D Volkow, Rong X. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World psychiatry : official journal of the World Psychiatric Association (WPA). 2021-12-12. PMID:34612005. |
when we matched sud and non-sud individuals for lifetime comorbidities and adverse socioeconomic determinants of health, the risk for breakthrough infection no longer differed between these populations, except for patients with cannabis use disorder, who remained at increased risk (hr=1.55, 95% ci: 1.22-1.99). |
2021-12-12 |
2023-08-13 |
Not clear |
| Nir Treves, Noa Mor, Karel Allegaert, Hely Bassalov, Matitiahu Berkovitch, Orit E Stolar, Ilan Mato. Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis. Scientific reports. vol 11. issue 1. 2021-12-12. PMID:34873203. |
cannabidiol is associated with 50% reduction in seizures rate (relative risk (rr) = 1.69, 95% ci [1.20-2.36]) and caregiver global impression of change (median estimated difference = (- 1), 95%ci [- 1.39-(- 0.60)]) in dravet syndrome, compared to placebo. |
2021-12-12 |
2023-08-13 |
Not clear |
| Nir Treves, Noa Mor, Karel Allegaert, Hely Bassalov, Matitiahu Berkovitch, Orit E Stolar, Ilan Mato. Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis. Scientific reports. vol 11. issue 1. 2021-12-12. PMID:34873203. |
while cannabidiol was associated with a reduction in reported seizure events (rr = 0.59, 95% ci [0.36-0.97]), no association was found in products contained also tetrahydrocannabinol (rr = 1.35, 95% ci [0.46-4.03]). |
2021-12-12 |
2023-08-13 |
Not clear |
| Nir Treves, Noa Mor, Karel Allegaert, Hely Bassalov, Matitiahu Berkovitch, Orit E Stolar, Ilan Mato. Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis. Scientific reports. vol 11. issue 1. 2021-12-12. PMID:34873203. |
higher dose of cannabidiol was associated with decreased appetite (rr = 2.40, 95% ci [1.39-4.15]). |
2021-12-12 |
2023-08-13 |
Not clear |
| Sushupta M Vijapur, Natalie S Levy, Silvia S Martin. Cannabis use outcomes by past-month binge drinking status in the general United States population. Drug and alcohol dependence. vol 228. 2021-12-10. PMID:34508962. |
past-month binge drinking was positively associated with past-month (or: 3.72, 95 %ci: 3.56-3.93) and past-year (or: 3.90, 95 %ci: 3.74-4.06) cannabis use in adjusted regressions. |
2021-12-10 |
2023-08-13 |
Not clear |
| Sushupta M Vijapur, Natalie S Levy, Silvia S Martin. Cannabis use outcomes by past-month binge drinking status in the general United States population. Drug and alcohol dependence. vol 228. 2021-12-10. PMID:34508962. |
the adjusted odds of dsm-iv and dsm-5 cud among people who used cannabis were 15 % and 12 % higher among people who engaged in binge drinking than those who did not, respectively (or: 1.15, 95 %ci: 1.05, 1.26 and or: 1.12, 95 %ci: 1.03, 1.21). |
2021-12-10 |
2023-08-13 |
Not clear |
| Sushupta M Vijapur, Natalie S Levy, Silvia S Martin. Cannabis use outcomes by past-month binge drinking status in the general United States population. Drug and alcohol dependence. vol 228. 2021-12-10. PMID:34508962. |
conversely, the odds of past-month daily cannabis use among people who used cannabis and reported binge drinking was 18 % lower than those who did not (or: 0.82, 95 %ci: 0.74, 0.91). |
2021-12-10 |
2023-08-13 |
Not clear |
| Elizabeth A Evans, Eva Goldwater, Edward J Stanek, Penny Brierley-Bowers, David Buchanan, Jennifer M Whitehil. Prevalence and Correlates of Cannabis Use in Massachusetts after Cannabis Legalization and before Retail Sales. Journal of psychoactive drugs. vol 53. issue 2. 2021-12-05. PMID:33242292. |
21.1% [95% ci: 18.6, 23.6] of massachusetts adults reported past 30-day cannabis use. |
2021-12-05 |
2023-08-13 |
Not clear |
| Elizabeth A Evans, Eva Goldwater, Edward J Stanek, Penny Brierley-Bowers, David Buchanan, Jennifer M Whitehil. Prevalence and Correlates of Cannabis Use in Massachusetts after Cannabis Legalization and before Retail Sales. Journal of psychoactive drugs. vol 53. issue 2. 2021-12-05. PMID:33242292. |
among cannabis users, 56.0% [ci 49.1, 62.9] reported non-medical cannabis use, 15.5% [12.1, 18.9] reported medical cannabis use, and 28.5% [ci 22.3, 34.8] reported both types of use. |
2021-12-05 |
2023-08-13 |
Not clear |